Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27−0.09 (-25.05%)
Close on Nov 17, 2026Market cap $2.88MP/E –Yield –
Gelteq r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was A$628.61K, up 127.7% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$628.61K | +127.7% |
| FY2024 | Jun 30, 2024 | A$276.06K | -58.5% |
| FY2023 | Jun 30, 2023 | A$665.04K | – |
See a number that looks wrong?